Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

CYC First Half Trading Update (ASX:CYC)

Cyclopharm Limited (ASX: CYC) is pleased to provide the following update on its trading performance for first half of 2021. Following a review of the company’s unaudited management accounts...read more

Cyclopharm USFDA Update (ASX:CYC)

Cyclopharm Limited (ASX: CYC) announcesthat the US Food and Drug Administration (USFDA) has provided a Complete Response Letter (CRL) for the New Drug Application (NDA) for TechnegasTM. The USFDA ha...read more

Cyclopharm Amended Constitution (ASX:CYC)

Please find attached CYC’s Amended Constitution adopted by special resolution at today’s Annual General Meeting. For more information, download the attached PDF.

Cyclopharm - Results of Meeting (ASX:CYC)

In accordance with Listing Rule 3.13.2 and section 251AA of the Corporations Act, we advise details of the resolutions and the proxies received in respect of each resolution in the attached voting r...read more

Cyclopharm - Becoming a substantial holder from MUFG (ASX:CYC)

To view the notice of initial substantial holder, download the attached PDF.

Cyclopharm - Ceasing to be a substantial holder from MUFG (ASX:CYC)

To view the notice of ceasing to be a substantial holder, download the attached PDF.

Cyclopharm - Managing Director's Address to Shareholders (ASX:CYC)

Good morning ladies and gentlemen, my name is James McBrayer, the Managing Director of Cyclopharm. Slide 7 – Financial Highlights To begin, I would like to provide a review of our financ...read more

Cyclopharm - 2021 AGM Presentation (ASX:CYC)

To view the presentation, download the attached PDF.

Cyclopharm - Chairman's Address to Shareholders (ASX:CYC)

Good morning ladies and gentlemen, and fellow shareholders. Thank you for joining us for today’s virtual Annual General Meeting of Cyclopharm Limited. My name Is David Heaney, Chairman of t...read more

Cyclopharm - Confirmation of Technegas USFDA Timetable (ASX:CYC)

Cyclopharm Limited’s (ASX: CYC) provides the following update of the US Food & Drug Administration’s (USFDA) timetable in respect of approval of the Company’s New Drug Applicat...read more

Cyclopharm Results Summary (ASX:CYC)

Cyclopharm Limited (ASX: CYC) is pleased to provide the following update on its business and financial performance for FY2020, including progress towards gaining United States Food and Drug Administ...read more

Cyclopharm - Preliminary Final Report (ASX:CYC)

To view the report, download the attached PDF.

Cyclopharm - Dividend/Distribution (ASX:CYC)

To view the Notification of dividend / distribution, download the attached PDF.

Cyclopharm Receives $3.1M R&D Tax Incentive for FY2020 (ASX:CYC)

AusIndustry has approved Cyclopharm Limited’s (ASX: CYC) inclusion of certain expensed costs associated with its overseas research and domestic development activities as part of its applicatio...read more